
Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans
Keywords: داپلر; Regadenoson; coronary flow velocity; myocardial perfusion imaging; A2A adenosine; Doppler; pharmacologic stress agent;